Pi-Cardia today announced the first commercial procedures with its ShortCut leaflet modification device for enabling heart ...

First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treati ...

Transcatheter aortic valve replacement or implantation (TAVR ... This reduces the risk of perivalvular leakage and blockage of the electrical signal from the atria to the ventricles, which are ...

Coronary artery disease ... The healthy blood vessel will be attached to the heart above and below a blockage to allow blood to bypass the obstruction and flow more freely. Once your surgeon ...

The agency also gave clearance to the ShortCut leaflet modification device that facilitates valve-in-valve transcatheter ...